BayWa's Restructuring Hangs on Creditor Talks and Legal Probes

BayWa faces a 2026 deadline to secure creditor support amid criminal probes into former CEOs and a €4B funding shortfall. Asset sales are insufficient to plug the gap.

The fate of German conglomerate BayWa is being decided not in the marketplace, but in closed-door negotiations with its creditors and courtrooms. As management races to plug a multi-billion-euro funding gap, a parallel legal crisis is escalating, leaving investors to navigate without audited financials until late 2026.

A critical deadline looms this autumn. The entire restructuring plan depends on lenders DZ Bank and HVB agreeing to extend a standstill agreement until autumn 2026. Should they refuse, the StaRUG insolvency plan finalized in May 2025 loses its legal foundation, stripping management of its operational basis. The urgency is underscored by actions within BayWa's own banking ownership; the Bavarian cooperative banks have already written down 60% of a €220 million promissory note, a €132 million hit reflected in the 2024 accounts.

Legal Onslaught Compounds Financial Strain

While the financial overhaul stumbles, a significant legal front has opened. The trigger was a BaFin reprimand in October 2025, which found that the 2023 consolidated accounts may have misrepresented the company's financial position and funding risks. Law firm TILP is now pursuing damages claims on behalf of shareholders who bought stock between January 2022 and January 2026.

In a parallel criminal probe, the Munich I public prosecutor's office is investigating former CEOs, including Klaus Josef Lutz and Marcus Pöllinger, on suspicion of breach of trust and the intentional misrepresentation of liquidity risks in the 2023 annual report. Searches were conducted in January. All accused are presumed innocent.

The legal fallout extends to auditor PwC. The firm issued an unqualified audit opinion for 2023 without flagging existential risks, a requirement under German commercial law. The audit oversight body Apas has initiated professional disciplinary proceedings. BayWa has put the audit mandate for 2026 out to tender, with PwC conducting its final audit for the 2025 fiscal year.

Asset Sales Progress, But Fall Short

On the divestment front, progress is mixed. The sale of Cefetra is complete, with a final payment of €45 million due by April 30, 2026. Its deconsolidation and the use of proceeds are expected to reduce group bank loans by over €600 million.

The process to sell New Zealand fruit subsidiary T&G Global, managed by Goldman Sachs, is underway. BayWa holds roughly 74% of T&G, which returned to profitability in 2024 with a net profit of $16 million on revenue of $1.3 billion. However, a potential sale, expected to yield around €300 million, is complicated by minority shareholder Joy Wing Mau Group's nearly 20% stake. T&G itself states no final decision has been made. Crucially, even a successful sale would only cover a fraction of the capital needed; BayWa has secured just €1.3 billion of its €4 billion target.

The most severe structural problem is the renewable energy unit BayWa r.e. Plans to sell a 51% stake for approximately €1.7 billion have been scrapped. Its earnings outlook has been slashed; instead of an EBITDA of €230 million projected for 2028, BayWa now forecasts just €150 million for 2030. This downgrade is largely due to the U.S. "One Big Beautiful Bill Act," which significantly cut subsidies for renewable energy—a major blow in a key market where over 530 megawatts of project capacity was sold in 2024.

Investors Left Flying Blind

For shareholders, the situation is particularly opaque. The 2025 group financial statements, delayed pending the revaluation of BayWa r.e., are not expected until the fourth quarter of 2026. Until then, investors lack certified figures. This information vacuum coincides with a near-complete overhaul of the supervisory board, with three members—including Monika Hohlmeier and Michael Höllerer as of late March—having recently stepped down.

The company's long-term goal is to shrink the former €24 billion conglomerate to roughly €10 billion in revenue by 2028. With the stock trading about 25% below its level from twelve months ago, the path to that target is fraught. Two dates will now define BayWa's immediate future: the creditor decision this autumn and the publication of audited accounts, both unlikely before Q4 2026.